We guide you through every step of the 15-day response window with expert strategy, communication, and execution. Here’s how we do it, knowing this process can be adapted to any situation.
Phase 1: Immediate Engagement
-
Rapid risk analysis of Form 483 observations
-
Assignment of FDA-experienced response leads
-
Secure document collaboration setup
-
Strategic response plan kickoff
-
Phase 2: Root Cause and CAPA Development
-
Facilitation of thorough root cause analysis
-
Drafting of corrective actions and systemic fixes
-
CAPA planning aligned with realistic timelines
-
Supporting documentation package assembly
-
Phase 3: Response Drafting and Refinement
-
Draft responses tailored to each observation
-
Review by former FDA investigators
-
Collaborative editing with your team
-
Final sign-off and preparation for submission
-
Phase 4: Submission and Beyond
-
FDA submission with complete documentation
-
Coaching for follow-up communications (if desired)
-
Mock inspections and sustainability planning (if desired)
-
Ongoing compliance monitoring and training support (if desired)
-